The Evaluation of Elecsys HIV Combi Reagent in Detecting HIV Antigen and Antibody

ZHOU Yan,SONG Binbin,ZHEN Xiaohong,GUO Wei,PAN Baishen
DOI: https://doi.org/10.3969/j.issn.1673-8640.2011.12.013
IF: 1.865
2011-01-01
Laboratory Medicine
Abstract:Objective To evaluate the performance of Roche Elecsys HIV Combi reagent in detecting HIV p24-antigen and HIV1/2 antibody.Methods A total of 1 327 serum samples were collected for healthy subjects,patients with human immunodeficiency virus(HIV) infection and patients with antibody positive and high-risk hepatitis C virus(HCV).The 1 327 serum samples were detected by Roche cobas e411 Elecsys HIV Combi reagent and Vironostika Uni-FormII plus O HIV reagent,respectively.The both reagents were used to detect 51 serum samples of 7 seroconversion panels from American BBI company,and the analytical performance,consistency and the sensitivity of seroconversion were evaluated.Roche Elecsys HIV Combi reagent was as evaluation reagent,and Vironostika Uni-Form II plus O HIV reagent was as reference reagent.Results The Roche Elecsys HIV Combi reagent had good within-run and interday precisions,which met the clinical requirements.The consistency of the results of the 2 reagents was good.The sensitivity of seroconversion of Roche Elecsys HIV Combi reagent was 5.1 ahead of the Vironostika Uni-Form II plus O HIV reagent.Conclusions Roche Elecsys HIV Combi reagent has a good precision and sensitivity of seroconversion,which can provide the reference for early screening,diagnosing and follow-up monitoring HIV infection.
What problem does this paper attempt to address?